| Stereochemistry | RACEMIC |
| Molecular Formula | C21H30N4O4 |
| Molecular Weight | 402.4873 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC1=CC(N)=C(C=C1C(=O)NC2CCN(CC3CCC=CC3)CC2)[N+]([O-])=O
InChI
InChIKey=ZDLBNXXKDMLZMF-UHFFFAOYSA-N
InChI=1S/C21H30N4O4/c1-2-29-20-13-18(22)19(25(27)28)12-17(20)21(26)23-16-8-10-24(11-9-16)14-15-6-4-3-5-7-15/h3-4,12-13,15-16H,2,5-11,14,22H2,1H3,(H,23,26)
Cinitapride is an agonist of 5-HT4 and 5-HT1 receptors and antagonist of 5-HT2 receptors. Cinitapride is marketed worldwide for the treatment of gastrointestinal disorders related to motility such as indigestion or functional or non-ulcer dyspepsia, gastroesophageal reflux diseases, delay in gastric emptying and vomiting.
Approval Year
PubMed
ACTIVE MOIETY
